Modulation of tracheal smooth muscle responses in inducible T-cell kinase knockout mice

Tanna Janelle Boyer, Avery August, Abdellaziz Ben-Jebria

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

It has been shown that the Tec family nonreceptor tyrosine kinase inducible T cell kinase (ITK) plays a role in the activation of naïve T cells and in the differentiation of T helper (T H2)-type cells producing cytokines in a model of allergic inflammation, thereby possibly indirectly mediating hyperresponsivenes of airway smooth muscle tone. Using excised tracheae from wild type (WT) mice and those lacking ITK, we conducted a series of in vitro experiments in which isometric smooth muscle tones were assessed in response to several agonists to determine whether the absence of ITK would affect the responsiveness of tracheal smooth muscle cells. The resulting change in contractile responses was evaluated by measuring agonist cumulative concentration-response curves (CCRC). Our results indicate that the cholinergic agonist acetylcholine (ACh) and its analog carbachol (CCh) exhibited comparable CCRC profiles in contracting isolated tracheae from both WT and ITK -/- mice, with no alteration in their efficacies. However, the EC 50 values for the two agonists were found to be significantly higher in ITK -/- tracheae than in those from WT mice, suggesting an alteration of the potencies of these cholinergic agonists in the trachea of ITK -/- mice. Moreover, we found that the depolarizing agent potassium chloride (KCl) had a significantly lower efficacy in contracting ITK -/- tracheae compared to those from WT mice. This difference in KCl efficacy was abolished in the presence of a calcium (Ca 2+) voltage-dependent channel (VDC) agonist, Bay K8644, suggesting a modulation of the KCl induced permeability of VDC Ca 2+ channels in the trachea of ITK -/- mice. Taken together, these results suggest that the presence of ITK may play a modulating role in the pharmacomechanical as well as in the electromechanical coupling of airway smooth muscle contraction.

Original languageEnglish (US)
Pages (from-to)301-308
Number of pages8
JournalPulmonary Pharmacology and Therapeutics
Volume17
Issue number5
DOIs
StatePublished - Oct 1 2004

Fingerprint

Knockout Mice
Smooth Muscle
Muscle
Modulation
Trachea
Cholinergic Agonists
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
emt protein-tyrosine kinase
Electromechanical coupling
T-cells
Potassium Chloride
Carbachol
Electric potential
Muscle Contraction
Helper-Inducer T-Lymphocytes
Protein-Tyrosine Kinases
Acetylcholine
Smooth Muscle Myocytes
Cell Differentiation
Permeability

Keywords

  • Acetylcholine
  • Carbachol
  • Mouse tracheae
  • Potassium chloride
  • Smooth muscle contraction
  • T helper cells type 2

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Biochemistry, medical
  • Pharmacology (medical)

Cite this

Modulation of tracheal smooth muscle responses in inducible T-cell kinase knockout mice. / Boyer, Tanna Janelle; August, Avery; Ben-Jebria, Abdellaziz.

In: Pulmonary Pharmacology and Therapeutics, Vol. 17, No. 5, 01.10.2004, p. 301-308.

Research output: Contribution to journalArticle

Boyer, Tanna Janelle ; August, Avery ; Ben-Jebria, Abdellaziz. / Modulation of tracheal smooth muscle responses in inducible T-cell kinase knockout mice. In: Pulmonary Pharmacology and Therapeutics. 2004 ; Vol. 17, No. 5. pp. 301-308.
@article{f445a375ce4247df8ffcf3c9077d0a35,
title = "Modulation of tracheal smooth muscle responses in inducible T-cell kinase knockout mice",
abstract = "It has been shown that the Tec family nonreceptor tyrosine kinase inducible T cell kinase (ITK) plays a role in the activation of na{\"i}ve T cells and in the differentiation of T helper (T H2)-type cells producing cytokines in a model of allergic inflammation, thereby possibly indirectly mediating hyperresponsivenes of airway smooth muscle tone. Using excised tracheae from wild type (WT) mice and those lacking ITK, we conducted a series of in vitro experiments in which isometric smooth muscle tones were assessed in response to several agonists to determine whether the absence of ITK would affect the responsiveness of tracheal smooth muscle cells. The resulting change in contractile responses was evaluated by measuring agonist cumulative concentration-response curves (CCRC). Our results indicate that the cholinergic agonist acetylcholine (ACh) and its analog carbachol (CCh) exhibited comparable CCRC profiles in contracting isolated tracheae from both WT and ITK -/- mice, with no alteration in their efficacies. However, the EC 50 values for the two agonists were found to be significantly higher in ITK -/- tracheae than in those from WT mice, suggesting an alteration of the potencies of these cholinergic agonists in the trachea of ITK -/- mice. Moreover, we found that the depolarizing agent potassium chloride (KCl) had a significantly lower efficacy in contracting ITK -/- tracheae compared to those from WT mice. This difference in KCl efficacy was abolished in the presence of a calcium (Ca 2+) voltage-dependent channel (VDC) agonist, Bay K8644, suggesting a modulation of the KCl induced permeability of VDC Ca 2+ channels in the trachea of ITK -/- mice. Taken together, these results suggest that the presence of ITK may play a modulating role in the pharmacomechanical as well as in the electromechanical coupling of airway smooth muscle contraction.",
keywords = "Acetylcholine, Carbachol, Mouse tracheae, Potassium chloride, Smooth muscle contraction, T helper cells type 2",
author = "Boyer, {Tanna Janelle} and Avery August and Abdellaziz Ben-Jebria",
year = "2004",
month = "10",
day = "1",
doi = "10.1016/j.pupt.2004.07.002",
language = "English (US)",
volume = "17",
pages = "301--308",
journal = "Pulmonary Pharmacology and Therapeutics",
issn = "1094-5539",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - Modulation of tracheal smooth muscle responses in inducible T-cell kinase knockout mice

AU - Boyer, Tanna Janelle

AU - August, Avery

AU - Ben-Jebria, Abdellaziz

PY - 2004/10/1

Y1 - 2004/10/1

N2 - It has been shown that the Tec family nonreceptor tyrosine kinase inducible T cell kinase (ITK) plays a role in the activation of naïve T cells and in the differentiation of T helper (T H2)-type cells producing cytokines in a model of allergic inflammation, thereby possibly indirectly mediating hyperresponsivenes of airway smooth muscle tone. Using excised tracheae from wild type (WT) mice and those lacking ITK, we conducted a series of in vitro experiments in which isometric smooth muscle tones were assessed in response to several agonists to determine whether the absence of ITK would affect the responsiveness of tracheal smooth muscle cells. The resulting change in contractile responses was evaluated by measuring agonist cumulative concentration-response curves (CCRC). Our results indicate that the cholinergic agonist acetylcholine (ACh) and its analog carbachol (CCh) exhibited comparable CCRC profiles in contracting isolated tracheae from both WT and ITK -/- mice, with no alteration in their efficacies. However, the EC 50 values for the two agonists were found to be significantly higher in ITK -/- tracheae than in those from WT mice, suggesting an alteration of the potencies of these cholinergic agonists in the trachea of ITK -/- mice. Moreover, we found that the depolarizing agent potassium chloride (KCl) had a significantly lower efficacy in contracting ITK -/- tracheae compared to those from WT mice. This difference in KCl efficacy was abolished in the presence of a calcium (Ca 2+) voltage-dependent channel (VDC) agonist, Bay K8644, suggesting a modulation of the KCl induced permeability of VDC Ca 2+ channels in the trachea of ITK -/- mice. Taken together, these results suggest that the presence of ITK may play a modulating role in the pharmacomechanical as well as in the electromechanical coupling of airway smooth muscle contraction.

AB - It has been shown that the Tec family nonreceptor tyrosine kinase inducible T cell kinase (ITK) plays a role in the activation of naïve T cells and in the differentiation of T helper (T H2)-type cells producing cytokines in a model of allergic inflammation, thereby possibly indirectly mediating hyperresponsivenes of airway smooth muscle tone. Using excised tracheae from wild type (WT) mice and those lacking ITK, we conducted a series of in vitro experiments in which isometric smooth muscle tones were assessed in response to several agonists to determine whether the absence of ITK would affect the responsiveness of tracheal smooth muscle cells. The resulting change in contractile responses was evaluated by measuring agonist cumulative concentration-response curves (CCRC). Our results indicate that the cholinergic agonist acetylcholine (ACh) and its analog carbachol (CCh) exhibited comparable CCRC profiles in contracting isolated tracheae from both WT and ITK -/- mice, with no alteration in their efficacies. However, the EC 50 values for the two agonists were found to be significantly higher in ITK -/- tracheae than in those from WT mice, suggesting an alteration of the potencies of these cholinergic agonists in the trachea of ITK -/- mice. Moreover, we found that the depolarizing agent potassium chloride (KCl) had a significantly lower efficacy in contracting ITK -/- tracheae compared to those from WT mice. This difference in KCl efficacy was abolished in the presence of a calcium (Ca 2+) voltage-dependent channel (VDC) agonist, Bay K8644, suggesting a modulation of the KCl induced permeability of VDC Ca 2+ channels in the trachea of ITK -/- mice. Taken together, these results suggest that the presence of ITK may play a modulating role in the pharmacomechanical as well as in the electromechanical coupling of airway smooth muscle contraction.

KW - Acetylcholine

KW - Carbachol

KW - Mouse tracheae

KW - Potassium chloride

KW - Smooth muscle contraction

KW - T helper cells type 2

UR - http://www.scopus.com/inward/record.url?scp=5144221414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5144221414&partnerID=8YFLogxK

U2 - 10.1016/j.pupt.2004.07.002

DO - 10.1016/j.pupt.2004.07.002

M3 - Article

C2 - 15477126

AN - SCOPUS:5144221414

VL - 17

SP - 301

EP - 308

JO - Pulmonary Pharmacology and Therapeutics

JF - Pulmonary Pharmacology and Therapeutics

SN - 1094-5539

IS - 5

ER -